Fresenius | FRE - Sales Revenues

Stock Price
51.10
Daily Change
0.74 1.47%
Monthly
6.30%
Yearly
31.26%
Q1 Forecast
50.68

Fresenius reported EUR5.48B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
BASF EUR 14.33B 1.44B Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Beiersdorf EUR 2.35B 150M Sep/2025
DaVita Healthcare Partners USD 3.62B 200M Dec/2025
Demant DKK 6.26B 810M Dec/2025
E.ON EUR 21.19B 5.23B Dec/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.48B 100M Sep/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Getinge SEK 11.07B 3.2B Dec/2024
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GN Store Nord DKK 4.68B 720M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
RWE EUR 3.21B 510M Sep/2025
Sanofi EUR 11.3B 1.13B Dec/2025
Smith & Nephew USD 2.96B 134M Dec/2025